Verrica Pharmaceuticals Inc.
General ticker "VRCA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $56.1M (TTM average)
Verrica Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 19.1%.
Estimated limits based on current volatility of 3.3%: low 6.34$, high 6.78$
Factors to consider:
- Earnings expected soon, date: 2026-05-12 bmo
- Total employees count: 71 (-29.0%) as of 2024
- Top business risk factors: Liquidity and credit risks, Limited operating history, Product returns exceeding reserves, Economic downturns and volatility, Third-party risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.48$, 9.55$]
- 2026-12-31 to 2027-12-31 estimated range: [3.37$, 9.15$]
Financial Metrics affecting the VRCA estimates:
- Positive: with PPE of -5.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -20.33 <= 0.07
- Positive: Investing cash flow per share per price, % of 0 > -0.65
- Positive: Inventory ratio change, % of -20.84 <= -0.75
- Positive: 42.60 < Shareholder equity ratio, % of 52.50 <= 64.25
- Negative: negative Net income
Short-term VRCA quotes
Long-term VRCA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.59MM | $7.48MM | $35.58MM |
| Operating Expenses | $68.35MM | $73.40MM | $47.52MM |
| Operating Income | $-65.76MM | $-65.92MM | $-11.94MM |
| Non-Operating Income | $-1.24MM | $-10.66MM | $-5.95MM |
| Interest Expense | $3.96MM | $9.41MM | $7.74MM |
| R&D Expense | $20.30MM | $11.84MM | $8.86MM |
| Income(Loss) | $-67.00MM | $-76.58MM | $-17.89MM |
| Profit(Loss)* | $-67.00MM | $-76.58MM | $-17.89MM |
| Stockholders Equity | $19.76MM | $-9.86MM | $24.74MM |
| Inventory | $1.02MM | $2.46MM | $2.24MM |
| Assets | $81.60MM | $54.13MM | $47.13MM |
| Operating Cash Flow | $-38.58MM | $-60.93MM | $-17.63MM |
| Capital expenditure | $0.36MM | $0.03MM | $0.00MM |
| Investing Cash Flow | $-0.36MM | $-0.02MM | $0.00MM |
| Financing Cash Flow | $74.21MM | $37.73MM | $1.45MM |
| Earnings Per Share** | $-14.78 | $-14.78 | $-1.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.